<div class="container">

<table style="width: 100%;"><tr>
<td>breast</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Sample data from breast cancer expression</h2>

<h3>Description</h3>

<p>The example dataset comprises three lists of microarray results (differential gene
expression) from three breast cancer studies:
</p>

<ol>
<li>
<p> Strong Time Dependence of the 76-Gene Prognostic Signature (2007) labeled TransBig
</p>
</li>
<li>
<p> MicroArray Quality Control Phase II Project (2010) labeled MDCC
</p>
</li>
<li>
<p> A Clinically Relevant Gene Signature in Triple-Negative and Basal-Like Breast Cancer (2011) labeled Pusztai
</p>
</li>
</ol>
<p>Only genes (unique gene symbols) common to all studies are considered, therefore
each of the three lists has the length of N = 917.
</p>


<h3>Usage</h3>

<pre><code class="language-R">data(breast)</code></pre>


<h3>Format</h3>

<p>data.frame</p>


<h3>Source</h3>


<ol>
<li>
<p> TransBig: <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=gse7390">GEO GSE7390</a>
</p>
</li>
<li>
<p> MDCC: <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE20194">GEO GSE20194</a>
</p>
</li>
<li>
<p> Pusztai: <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE20271">GEP GSE20271</a>
</p>
</li>
</ol>
<h3>References</h3>

<p>TransBig: Desmedt C, Piette F, Loi S, Wang Y et al. (2007).  Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res, 1;13(11):3207-14. PMID: 17545524
</p>
<p>MDACC: Shi L, Campbell G, Jones WD, Campagne F et al. (2010). The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol;28(8):827-38. PMID: 20676074
</p>
<p>Pusztai: Tabchy A., Valero V., Vidaurre T., Lluch A. et al. (2010). Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer. Clin Cancer Res 1;16(21):5351-61. PMID: 20829329
</p>


</div>